Vir Biotechnology (VIR) Return on Sales (2018 - 2026)
Vir Biotechnology (VIR) posted Return on Sales of 43.34% for Q1 2026, down 646870.77% sequentially from 0.01% in Q4 2025, and down 4294.0% YoY from 1.03% in Q1 2025.
Vir Biotechnology (VIR) Return on Sales (2018 - 2026) Analysis & Trends
Vir Biotechnology has reported Return on Sales for 9 years, with the latest figure at 43.34% in Q1 2026.
- Quarterly Return on Sales fell 4294.0% year-over-year to 43.34% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.07% (up 21.0% YoY) and the FY2025 annual result came in at 0.06%, up 1.0% from the prior year.
- Return on Sales retreated to 43.34% in Q1 2026 per VIR's latest filing, from 0.01% in the prior quarter.
- Over five years, Return on Sales peaked at 0.0% in Q3 2022 and troughed at 43.34% in Q1 2026.
- A 5-year average of 3.19% and a median of 0.08% in 2024 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2022 and 2026: Return on Sales surged 86 bps in 2022, then tumbled 4294 bps in 2026.
- Over 5 years, Return on Sales stood at 0.02% in 2022, then sank by 236 bps to 0.07% in 2023, then slipped by 22 bps to 0.08% in 2024, then soared by 92 bps to 0.01% in 2025, then sank by 646871 bps to 43.34% in 2026.
- According to Business Quant data, Return on Sales over the past three periods registered 43.34%, 0.01%, and 6.8% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Vir Biotechnology | 1.56 Bn | 1.56 Bn | 238.95 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | -43.34% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -6.80% |
| Jun 30, 2025 | -0.91% |
| Mar 31, 2025 | -0.40% |
| Dec 31, 2024 | -0.08% |
| Sep 30, 2024 | -0.90% |
| Jun 30, 2024 | -0.45% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.07% |
| Sep 30, 2023 | -0.62% |
| Jun 30, 2023 | -0.51% |
| Mar 31, 2023 | -0.02% |
| Dec 31, 2022 | -0.02% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | -0.02% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.01% |
| Sep 30, 2021 | 0.01% |